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Summary
 
Induction of antigen-specific suppression elicited by environmental insults, such as ultraviolet
(UV)-B radiation in sunlight, can inhibit an effective immune response in vivo and may con-
tribute to the outgrowth of UV-induced skin cancer. Although UV-induced DNA damage is
known to be an initiating event in the immune suppression of most antigen responses, the un-
derlying mechanism(s) of such suppression remain undefined. In this report, we document that
Fas ligand (FasL) is critical for UV-induced systemic immune suppression. Normal mice acutely
exposed to UV exhibit a profound suppression of both contact hypersensitivity and delayed
type hypersensitivity (DTH) reactions and the development of transferable antigen-specific
suppressor cells. FasL-deficient mice exposed to UV lack both transferable suppressor cell activ-
ity and primary suppression to all antigens tested, with the exception of the DTH response to
allogeneic spleen cells. Interestingly, suppression of this response is also known to occur inde-
pendently of UV-induced DNA damage. Delivery of alloantigen as protein, rather than intact
cells, restored the requirement for FasL in UV-induced immune suppression of this response.
These results substantiate that FasL/Fas interactions are essential for systemic UV-induced sup-
pression of immune responses that involve host antigen presentation and suggest an interrela-
tionship between UV-induced DNA damage and FasL in this phenomenon. Collectively, our
results suggest a model whereby UV-induced DNA damage disarms the immune system in a
manner similar to that observed in immunologically privileged sites.
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E
 
xposure to UV-B radiation from sunlight is a signifi-
cant worldwide environmental hazard. UV exposure
induces the most common malignancy in humans, skin
cancer, with an estimated 1,000,000 cases per year in the
United States (1). UV exposure also significantly down-
modulates immune responses, exacerbating a number of in-
fectious diseases and permitting the outgrowth of highly
antigenic UV-induced skin tumors in mice (1, 2). The ef-
fects of UV on the immune system have been clinically ex-
ploited to attenuate pathophysiological responses associated
with autoimmune disease in the skin (e.g., psoriasis), trans-
fusion-associated graft-versus-host disease, and tumor growth
(e.g., cutaneous T cell lymphoma) (3–5). Elucidating the
mechanism(s) underlying UV-induced immunosuppression
may permit significant advances in the therapeutic use of
UV light and define a target for intervention in infectious
diseases adversely affected by UV exposure. Moreover, the
contribution of UV-induced immune suppression to skin
carcinogenesis could be more accurately defined.
A large body of evidence supports the concept that ex-
posure to UV radiation can suppress cellular immune
responses in animals and humans to antigens applied both
locally (at the site of irradiation) and distally (at a nonirradi-
ated [NR]
 
1
 
 site) (6). Acute exposure to UV-B radiation al-
ters the local site such that epicutaneous application of hap-
ten fails to induce contact hypersensitivity (CHS) and instead
induces tolerance in UV-B–susceptible mice (7, 8). Acute
UV-B exposure can also result in diminished CHS and de-
layed type hypersensitivity (DTH) responses when antigens
are applied epicutaneously or subcutaneously, respectively,
at NR sites (6, 9, 10). Suppression of immune responses to
antigens administered at distant, NR sites is known as sys-
temic immune suppression and is characterized by the gen-
eration of antigen-specific splenic T suppressor cells (11–
13). Although the phenotype and mode of action of the
T suppressor cell population remain largely uncharacterized,
 
1
 
Abbreviations used in this paper: 
 
CHS, contact hypersensitivity; DTH, de-
layed type hypersensitivity; FasL, Fas ligand; NR, nonirradiated; RT, re-
verse transcriptase; UVR, UV-irradiated. 
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previous studies have documented that UV-induced im-
mune suppression can be transferred to naive, NR animals
by CD4
 
1
 
 cells from UV-irradiated (UVR), antigen-primed
mice (14, 15). Suppressor cells cannot be elicited by either
UVR or antigen alone but require the introduction of anti-
gen at a critical time after irradiation (16, 17). Suppressor
cell activity appears to be targeted to the Th population and
requires IL-10 for both induction and function (18–20).
Data from a number of laboratories suggest that one conse-
quence of UV-B exposure is a shift from a Th1- to a Th2-
type immune response, resulting in the suppression of CHS
and DTH induction and the generation and maintenance
of suppressor cells (19–24).
DNA damage (in the form of cyclobutane pyrimidine
dimers) has been identified as the initial photobiological
event triggering UV-induced systemic immune suppression
to most antigens in the mouse (25, 26). Application of lipo-
somes containing bacteriophage T4 endonuclease V (an ex-
cision repair enzyme specific for pyrimidine dimers) to
UV-irradiated skin can repair the UV-induced DNA dam-
age in the skin, diminish UV-induced Th2-type cytokine
production, reverse UV-induced systemic suppression, and
prevent the generation of UV-induced suppressor cells
(27). Conversely, inducing DNA damage in the skin using
liposomes containing HindIII can result in the production
of Th2-type cytokines and the systemic suppression of CHS
and DTH responses (28, 29). These observations point to
DNA damage as a central mechanism underlying UV-induced
immune suppression and suggest a sequence of events in
which UV-initiated DNA damage triggers immunomodu-
latory cytokine production, the generation of CD4
 
1
 
 sup-
pressor cells, and immune perturbations leading to dimin-
ished CHS and DTH responses. Considering that primary
immunosuppression and the generation of suppressor cells
are dissociable events and that immunomodulatory cyto-
kine production is necessary, but not sufficient, to recapitu-
late the effects of UVR on the immune response, the exist-
ence of additional molecular linkages between DNA
damage and immune suppression is likely.
Recent evidence has documented the interactions of Fas
and Fas ligand (FasL) in the control of specific T cell–medi-
ated immune responses (reviewed in 30). This complemen-
tary receptor–ligand pair initiates apoptosis in activated
lymphocytes (31, 32) and is required for the maintenance
of peripheral tolerance (33) and immune privilege (34, 35).
Several lines of circumstantial evidence led us to query
whether Fas/FasL interactions were involved in systemic
UV-induced immune suppression. First, FasL is inducible
by DNA damage (36) and is upregulated in normal skin
following exposure to UV irradiation (3); second, Fas/FasL
interactions have been shown to mediate antigen-specific
immune suppression (35, 37); third, CD4
 
1
 
 T cells have
been documented to upregulate FasL expression and in-
duce autocrine, paracrine, or juxtacrine cell death (38–41);
and finally, the preferential elimination of Th1 cells by FasL
has been reported (42). To test the hypothesis that Fas and
FasL are involved in the immunomodulatory effects of UVR,
we investigated the biological consequences of Fas and
FasL loss of function using 
 
lpr
 
 and 
 
gld 
 
mice, respectively, on
UV-induced systemic immune suppression and the genera-
tion of transferable suppressor cells.
 
Materials and Methods
 
Mice.
 
Specific pathogen-free C3H/HeJ, Balb/c, and C57Bl/6
male mice were purchased from the National Cancer Institute–
Frederick Cancer Research Facility Animal Production Area.
C57Bl/6 
 
gld/gld
 
 and C57Bl/6 
 
lpr/lpr
 
 male mice were purchased
from The Jackson Laboratory. C3H/HeJ 
 
gld/gld
 
 male mice were
generated from a breeder colony maintained in our facility and
used between 8 and 14 wk of age. Mice were housed in a patho-
gen-free barrier facility accredited by the American Association
for Accreditation of Laboratory Animal Care, in accordance with
current U.S. Department of Agriculture, Department of Health
and Human Services, and National Institutes of Health regula-
tions and standards. All animal procedures were approved by the
Institutional Animal Care and Use Committee.
 
UV-B Radiation Source and Irradiation Procedure.
 
A bank of six
Westinghouse FS40 sunlamps was used as a source of UV radia-
tion as described (25).
 
DTH Responses to Candida albicans and Alloantigen.
 
DTH re-
sponses were assessed as previously described (9). In brief, mice
were shaved and exposed to UV-B radiation (2–5 and 15 kJ/m
 
2
 
for 
 
C
 
.
 
 albicans
 
 and alloantigen, respectively). 3 d later, mice were
sensitized by subcutaneous injection of antigen (10
 
7
 
 formalin-
fixed 
 
C
 
.
 
 albicans
 
 or 5 
 
3
 
 10
 
7
 
 Balb/c spleen cells or cell equiva-
lents). 6–10 d after antigen sensitization, mice were challenged by
injecting either purified 
 
C
 
.
 
 albicans
 
 protein (Allercheck, Inc.) or
10
 
7
 
 Balb/c spleen cells in the footpad. 24 h later, footpad swelling
was quantitated using a spring loaded micrometer (Swiss Preci-
sion Instruments). Specific footpad swelling (
 
D
 
swelling) was de-
termined by subtracting the footpad swelling in mice that were
challenged but not sensitized from that observed in mice that
were sensitized and challenged. Percent suppression was calcu-
lated as: % suppression 
 
5 
 
1 
 
2
 
 (
 
T 
 
2 
 
N
 
/
 
P 
 
2 
 
N
 
) 
 
3
 
 100, where 
 
N
 
 
 
5
 
negative control (response of unsensitized mice to challenge),
 
 P 
 
5
 
positive control (response of sensitized mice to challenge), and
 
T
 
 
 
5 
 
test group (response of mice given UV irradiation before
sensitization and challenge). Treatment groups consisted of 3–6
(typically 5) mice; both hind footpads were measured.
 
CHS Response to FITC.
 
CHS responses were determined as
previously described (43). In brief, for FITC responses, the ab-
dominal hair of mice was shaved, their ears protected with elec-
trical tape, and the animals exposed to UV-B radiation (2 kJ/m
 
2
 
).
3 d later, the dorsal hair was shaved and the animals sensitized by
epicutaneous application of 400 
 
m
 
l of 0.5% FITC (Isomer I, Al-
drich Chemical Co.) in acetone–dibutylphthalate (1:1, vol/vol).
5–7 d later, the mice were challenged by applying either 10 
 
m
 
l
0.5% FITC to the ventral and dorsal surfaces of both ears. Ear
swelling (
 
D
 
swelling) was quantitated 24 h later using a spring
loaded micrometer and specific ear swelling determined by sub-
tracting the ear swelling in mice challenged but not sensitized
from that observed in mice that had been sensitized and chal-
lenged; percent suppression was calculated as described for DTH
responses.
 
Transfer of Spleen Cells.
 
For transfer of splenic suppressor cell
populations, mice were killed, spleens harvested, and single cell
suspensions prepared immediately following DTH or CHS analy-
sis. Approximately 10
 
8
 
 spleen cells were injected into the tail
veins of NR, naive recipient mice and the animals immediately
sensitized by subcutaneous injection (10
 
7
 
 formalin-fixed 
 
C
 
.
 
 albi- 
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 or 5 
 
3
 
 10
 
7
 
 Balb/c spleen cells) or epicutaneous application
(400 
 
m
 
l 0.5% FITC). 6–10 d later, mice were challenged as de-
scribed above and DTH or CHS responses determined 24 h later.
 
Detection of FasL mRNA.
 
C3H/HeJ mice were shaved and
exposed to 15 kJ/m
 
2
 
 UV radiation as described above. 3 d after
UVR, mice were killed and inguinal, axillary, and brachial lymph
nodes harvested. Lymph nodes were mechanically dissociated
and washed, and RNA was extracted with Trizol (GIBCO
BRL) per manufacturer’s instructions. Reverse transcriptase (RT)
and PCR reactions were performed with the GeneAmp PCR kit
(Perkin-Elmer Corp.) using the following primer sequences:
FasL, 5
 
9
 
-ATCCCTCTGGAATGGGAAGA-3
 
9
 
 (forward), 5
 
9
 
-CCA-
TATCTGTCCAGTAGTGC-3
 
9
 
 (reverse); 
 
b
 
 actin, 5
 
9
 
-TCCTGT-
GGCATCCATGAAACT-3
 
9
 
 (forward), 5
 
9
 
-CTTCGTGAACGC-
CACGTGCTA-3
 
9
 
 (reverse). 35 cycles of PCR were performed:
30 s at 94
 
8
 
C, 45 s at 55
 
8
 
C, and 60 s at 72
 
8
 
C, using a Perkin-Elmer
Gene Amp 9600.
 
Statistical Analysis.
 
For DTH and CHS analysis, the probabil-
ity of no difference between treatment and controls was analyzed
in a factorial ANOVA using Fisher’s protected least significant
difference test with a 5% significance level. Statistical analyses
were performed with Statview software (Abacus Concepts; v4.5).
 
Results
 
UV-induced Systemic Immune Suppression Requires Fas/
FasL Interactions.
 
Normal mice exposed to a single dose of
UVR before immunization at an NR site with formalin-
fixed 
 
C. albicans 
 
or FITC exhibit a profound suppression of
DTH or CHS response, respectively. To address the poten-
tial role of Fas/FasL interactions in UVR-induced systemic
immune suppression, 
 
lpr
 
 or 
 
gld
 
 mice were evaluated for
UV-induced immune suppression of CHS and DTH re-
sponses. The 
 
lpr
 
 mutation encodes an abnormal Fas gene
containing an early retroviral transposon insertion that re-
sults in premature termination (44–47). Low levels of Fas
expression (up to 50% of the level observed in wild-type
mice) have been reported in 
 
lpr
 
 mice, demonstrating an in-
complete Fas loss in these animals (46, 48). Mice harboring
the 
 
gld
 
 mutation have a complete loss of biologically active
FasL as a result of a point mutation in the FasL gene (49–51).
The requirement for Fas/FasL interactions in UVR-induced
immune suppression was first evaluated by comparing re-
sponses in wild-type C3H/HeJ (C3H) and FasL-deficient
C3H/HeJ 
 
gld/gld
 
 (C3H/
 
gld
 
) mice. Both groups of animals
were exposed to a single dose of UVR and immunized 3 d
later at a distant NR site by epicutaneous application of
FITC or subcutaneous injection of 
 
C
 
.
 
 albicans
 
 (9). 6–10 d
later, mice were challenged either on the pinnae or in the
footpad with the sensitizing antigen to elicit CHS and
DTH responses, respectively. Representative results from
one such experiment are shown in Fig. 1. In wild-type C3H
mice, UVR exposure potently suppressed both CHS and
DTH responses compared with NR, positive control mice
(76 and 82% suppression, respectively; 
 
P 
 
, 
 
0.0001). In di-
rect contrast, UVR-exposed C3H/
 
gld
 
 mice exhibited no
such immune suppression. Similar results were observed in
C57Bl/6 (B6) and C57Bl/6 
 
gld/gld
 
 (B6/
 
gld
 
) mice for DTH
to 
 
C
 
. 
 
albicans
 
 (data not shown). Thus, when FasL is non-
functional, UVR-induced immune suppression is abrogated.
To explore the effects of diminished Fas function on
UVR-induced immune suppression, we next examined the
DTH response of wild-type B6 and Fas-deficient C57Bl/6
 
lpr/lpr
 
 (B6/
 
lpr
 
) mice acutely exposed to a single dose of UVR
and immunized with 
 
C
 
.
 
 albicans
 
. Results from a representa-
tive experiment are shown in Fig. 1. Unlike mice contain-
ing the 
 
gld
 
 mutation, DTH induction was significantly sup-
pressed in both UVR-treated B6/
 
lpr
 
 and wild-type B6
mice compared with NR control mice in each group. No-
tably, UV-induced suppression in 
 
lpr
 
 mice was only half
that observed in wild-type B6 mice with intact Fas expres-
sion (40% suppression in 
 
lpr
 
 mice compared with 83% in
wild-type mice). The observation that B6/
 
lpr
 
 mice have
intermediate sensitivity to UVR-induced immunosuppres-
sion is not likely the result of differences in genetic back-
ground between the two mouse strains, as B6/
 
gld
 
 mice also
exhibited a complete absence of UVR-induced immune
suppression (data not shown). Instead, these findings likely
reflect the leaky nature of the 
 
lpr
 
 mutation and, moreover,
suggest that the induction of Fas after UV exposure may
reestablish the capacity to induce systemic immune sup-
pression. Indeed, Fas upregulation has been recently re-
ported to occur in 
 
lpr
 
 mice exposed to gamma
 
 
 
irradiation
(52). Taken together, these results point toward a critical
requirement for Fas/FasL interactions in primary, UVR-
induced systemic suppression of CHS and DTH induction.
Earlier work in our laboratory demonstrated the pres-
ence of DNA damage (cyclobutane pyrimidine dimers) in
skin-derived dendritic cells up to 1 wk after a single acute
exposure of UVR (27). As DNA damage can induce FasL
expression, a potential mechanism for the requirement for
FasL in UV-mediated suppression might be the inappropri-
ate expression of FasL in the draining lymph nodes after
UVR. To explore this possibility, the skin-draining lymph
Figure 1. UV-induced systemic suppression of antigen-specific re-
sponses to FITC and C. albicans. Mice were exposed to UVR, sensitized
with antigen, and challenged, and Dswelling was determined 24 h later as
described in Materials and Methods. Values shown represent mean 6 SE
for five mice per group using measurements from two footpads per
mouse. 2, negative (challenge only); 1, positive (sensitized and chal-
lenged); and UV (UVR, sensitized, and challenged). **P , 0.0001 vs.
positive control. *P , 0.05 vs. positive control. 
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nodes from wild-type mice were removed 3 d after UVR
and FasL expression determined by RT-PCR. As shown in
Fig. 2, FasL mRNA was markedly induced in the lymph
nodes of mice that received 15 
 
kJ/m
 
2
 
 UVR but was unde-
tectable in untreated control animals. Specificity was dem-
onstrated using L929 murine fibroblasts and unactivated 
 
lpr/
lpr
 
 splenocytes as negative and positive controls for FasL
expression, respectively (53). FasL induction in the skin-
draining lymph nodes after UVR points to an interrelation-
ship with DNA damage and suggests a potential scenario in
which inappropriate FasL expression eliminates antigen-
responsive T cells (54) or serves to clonally expand a sup-
pressor cell population (55). Experiments are currently un-
derway to test these possibilities.
 
UV-induced Systemic Suppression of DTH to Alloantigen Does
Not Require FasL. UVR-induced suppression of the DTH
response to whole alloantigen differs from that of FITC or
C. albicans in that it is mediated by photoisomerization of
cis-urocanic acid and is UV-induced DNA damage–inde-
pendent (Kripke, M.L., unpublished observations). Such
findings suggest that UVR-induced suppression of the DTH
response to alloantigen differs mechanistically from that of
C. albicans. To evaluate the role of FasL in UVR-induced
immune suppression of DTH responses to whole alloanti-
gen, C3H, C3H/gld, B6, and B6/gld mice were exposed to
a single dose of UVR and immunized with intact Balb/c
spleen cells, and DTH responses were measured. In three
independent experiments, UVR exposure potently sup-
pressed DTH responses in both strains of FasL-deficient gld
mice (Fig. 3) at levels comparable to those of matched,
wild-type control mice. These results demonstrate that, in
contrast to other antigen systems tested (FITC and C. albi-
cans), primary UVR-induced suppression of DTH to whole
alloantigen can proceed in a manner independent of host-
derived FasL.
Presentation of Alloantigen Determines the Requirement for
Host-derived FasL in UVR-induced Immune Suppression. To
resolve the differences in FITC, C. albicans, and alloantigen
requirements for FasL in the mediation of UVR-induced
immune suppression, a more detailed analysis of alloimmu-
nization was undertaken. Whereas FITC and formalin-
fixed  C. albicans require processing and presentation by host
APC, whole allogeneic splenocytes may bypass such a re-
quirement through direct antigen presentation on the vari-
ous cell populations in the sensitizing inoculum. To this
end, we queried whether FasL was required for UVR-
induced suppression when allogeneic splenocytes were dis-
rupted before immunization. UVR-induced systemic suppres-
sion of responses to intact and disrupted allogeneic spleen cells
was compared in C3H and C3H/gld mice by exposing mice
to a single dose of UVR, immunizing 3 d later with either in-
tact or disrupted allogeneic Balb/c spleen cells, and challeng-
ing 6–10 d later with intact spleen cells to elicit a DTH re-
sponse. Disrupted allogeneic spleen cells were prepared by
several freeze–thaw cycles and sonication to insure uniform
dispersion. Results from one of two consistent experiments
are shown in Fig. 4. DTH responses were suppressed in
UVR-treated wild-type mice whether intact or disrupted al-
loantigen was used for sensitization (78 and 89% suppression,
respectively, compared with positive control mice; P ,
0.0001). In contrast to the potent suppression of DTH ob-
served in UVR-treated C3H/gld mice immunized with intact
allogeneic spleen cells (62% suppression; P , 0.0001), UVR-
treated C3H/gld mice immunized with disrupted alloge-
neic spleen cells failed to demonstrate such suppression.
The lack of primary, UV-induced immunosuppression in
FasL-deficient mice immunized with disrupted alloantigen is
in accordance with our findings using FITC and C. albicans
(Fig. 1), suggesting that such suppression is dependent upon
FasL and host-derived APC for antigen presentation.
Transfer of UV-induced Suppression Requires Donor-derived
FasL. Antigen-specific T suppressor cells capable of trans-
ferring antigen-specific suppression to a naive host exist in
the spleens of mice exposed to UVR and sensitized to anti-
Figure 2. FasL is induced in
skin-draining lymph nodes after
UVR. Skin-draining lymph
nodes were harvested from mice
that were NR and 3 d post-
UVR. RNA was extracted and
RT-PCR performed as de-
scribed in Materials and Meth-
ods. 2, negative control (L929 murine fibroblasts); 1, positive control
(lpr splenocytes); UV, UV-irradiated. Each lane represents a single mouse
analyzed.
Figure 3. Systemic suppres-
sion of alloantigen DTH re-
sponses in wild-type and FasL-
deficient (gld) mice. Mice were
exposed to UVR, sensitized with
intact Balb/c spleen cells, and
challenged, and Dswelling was
determined 24 h later as de-
scribed in Materials and Meth-
ods. Data are representative of
two experiments for C3H mice
and one for B6 mice. Values
shown represent mean 6 SE for
five mice per group using measurements from two footpads per mouse.
2, negative (challenge only); 1, positive (sensitized and challenged); and
UV (UVR, sensitized, and challenged). **P , 0.0001 vs. positive control.
Figure 4. Effect of antigen presentation on FasL requirement for UV sup-
pression. C3H and C3H/gld mice were exposed to UVR, sensitized with
whole or disrupted Balb/c spleen cells, subsequently challenged with whole
Balb/c spleen cells on day 10, and Dswelling was determined 24 h later as
described in Materials and Methods. Values shown represent mean 6 SE for
five mice per group using measurements from two footpads per mouse. 2,
negative (challenge only); 1, positive (sensitized and challenged); and UV
(UVR, sensitized, and challenged). **P , 0.0001 vs. positive control.1289 Hill et al.
gen (11–15). Although primary, UVR-mediated suppres-
sion was absent in FasL-deficient mice, it remained uncer-
tain whether transferable suppressor cell function was also
absent in such mice. To address this premise, we compared
suppressor cell activity in adoptively transferred spleen cells
from immunized, UVR-exposed wild-type and gld donors.
These experiments were carried out by exposing C3H and
C3H/gld mice to a single dose of UVR followed by immu-
nization and challenge with FITC, C. albicans, or alloanti-
gen. On the day that CHS and DTH responses were mea-
sured, spleens from UVR-exposed animals and NR control
animals were harvested and transferred into naive recipient
mice. Recipient mice were immediately sensitized with the
indicated antigen and received antigenic challenge 6–10 d
later. Mice receiving NR, antigen-primed spleen cells from
either C3H or C3H/gld donors showed potent CHS and
DTH responses to FITC and C. albicans, respectively. Ani-
mals that received spleen cells from UVR-exposed, anti-
gen-primed C3H mice demonstrated a suppression of both
CHS and DTH responses, confirming the presence of
UV-induced splenic suppressor cells as expected (Fig. 5). In
contrast, adoptively transferred UVR-exposed spleen cells
from C3H/gld mice primed with either FITC or C. albicans
failed to inhibit antigen sensitization in naive mice. Al-
though these experiments suggest a loss of transferable sup-
pressor cell activity in the absence of donor-derived FasL,
they are not definitive, as such mice also lack primary UVR-
mediated suppression, which may be essential for the sub-
sequent generation of transferable suppressor cells.
To this end, transferable suppression was also evaluated
in C3H/gld mice immunized with allogeneic spleen cells in
which primary, UVR-mediated immune suppression was in-
tact. For these experiments, spleen cells from UVR-exposed,
FasL-deficient C3H/gld (data not shown) or B6/gld mice
immunized with allogeneic spleen cells were transferred to
naive, matched wild-type recipients (Fig. 5). As expected,
spleen cells from wild-type mice that received UVR before
antigen priming showed potent suppressor cell activity
when transferred into matched wild-type recipients (Fig.
4). Consistent with our previous experiments, spleen cells
from FasL-deficient mice that received UVR before anti-
gen priming showed no such transferable suppressor cell
activity. That C3H/gld and B6/gld mice exhibited potent
UVR-induced primary suppression but not splenic sup-
pressor cell activity when immunized with allogeneic
whole spleen cells (Fig. 3) suggests that these events are
mechanistically dissimilar and that transferable suppression
is strictly dependent upon FasL expression on the donor
population. In further support of this premise, wild-type
mice that received UVR before immunization with dis-
rupted allogeneic spleen cells exhibited transferable suppres-
sor cell activity comparable to that of C3H mice immunized
with intact allogeneic spleen cells. Spleen cells from FasL-
deficient mice that received UVR before immunization
with disrupted alloantigen, however, again demonstrated
no such transferable suppressor cell activity (data not
shown). These results substantiate that donor-derived FasL
expression is uniformly required for the generation and/or
effector activity of UV-induced transferable suppressor cells
for all antigen systems tested.
Transfer of UV-induced Suppression Does Not Require Recip-
ient-derived FasL. In the experimental models above, we
have shown a stringent requirement for donor-derived FasL
in UV-mediated transferable suppression. To discern
whether FasL was also required in recipient mice, we evalu-
ated UV-induced transferable suppression in FasL-deficient
recipients. Such experiments were carried out by transferring
spleen cells from wild-type mice that received UVR before
immunization with C. albicans into either wild-type or FasL-
deficient recipient mice (C3H or C3H/gld). Results from
one such experiment are shown in Fig. 6. Consistent with
our previous findings (Fig. 5), spleen cells from UVR-
exposed,  C. albicans–immunized C3H donor mice suppressed
subsequent antigen responsiveness in naive C3H recipients
(58% suppression relative to positive control mice; P ,
0.0001). Similarly, UVR-exposed, C. albicans–immunized
C3H donor spleen cells markedly suppressed subsequent an-
tigen responsiveness in C3H/gld recipients (53% suppression
relative to positive control mice; P , 0.0001), ruling out a
requirement for recipient-derived FasL in transferable sup-
pression induced by UVR. No suppression was observed
when NR, C. albicans–immunized C3H splenocytes were
transferred to either C3H or C3H/gld recipients, confirming
a requirement for both UVR and antigen exposure in the
generation of suppressor cell activity (16, 17).
Discussion
Fas and FasL are complementary receptor–ligand pro-
teins that induce apoptosis in many cell types (30). Fas is
Figure 5. Adoptive transfer of UV-induced suppression by spleen cells
requires FasL. 108 spleen cells from indicated donors were injected intra-
venously into naive hosts, sensitized, and challenged with FITC, C. albi-
cans, and Balb/c spleen cells as described in Materials and Methods. Values
shown represent mean 6 SE for five mice per group using measurements
from two footpads per mouse. 2, negative (challenge only); 1, positive
(sensitized and challenged); NR, recipient of spleen cells from NR sensi-
tized donors, sensitized, and challenged; and UV, recipient of spleen cells
from UV-irradiated sensitized donors, sensitized, and challenged. **P ,
0.0001 vs. positive control.1290 FasL Required for UV-induced Systemic Immune Suppression
constitutively expressed in numerous tissues (56) and is rap-
idly upregulated in activated lymphocytes (31, 32). Al-
though constitutive FasL expression is restricted to only a
few tissues (57), transient FasL upregulation has been ob-
served in a variety of cell types after genotoxic damage or
cellular injury (3, 36, 58). Activated Fas1 lymphocytes can
upregulate FasL upon T cell receptor engagement (39–41).
Fas/FasL-induced apoptosis has been shown to play a criti-
cal role in the control of lymphocyte proliferation, periph-
eral tolerance, and specific immune responses occurring in
discrete organ environments (35, 59). The effect of UVR on
immune function shares several commonalities with Fas/
FasL-driven immunoregulation. UVR (6, 10), like FasL (35,
37), can mediate antigen-specific immune suppression. More-
over, UVR (19–23), like FasL (42), has been shown to shift
the activation of T cells from a Th1- to a Th2-type im-
mune response. Therefore, we were prompted to examine
the role of Fas/FasL interactions in UVR-induced immune
suppression.
Our observations are important in that they identify FasL
as a fundamental constituent of both primary and transfer-
able antigen-specific suppression induced by UVR (Table
I). The central role of FasL in UV-induced systemic sup-
pression of CHS and DTH responses varies from that of
Th2-like immunomodulatory cytokines and cis-urocanic
acid, which are not shared conjointly in the suppression of
CHS and DTH responses (19–21; Kripke, M.L., unpub-
lished observations). For example, IL-10 appears to be es-
sential for systemic UVR-induced suppression of DTH re-
sponses (20), whereas TNF-a is essential for CHS suppression
(19, 60). The selective requirement of FasL for UVR-
mediated suppression of CHS responses to FITC and DTH
responses to Candida, but not alloantigen, is reminiscent of
our previous finding that repair of UV-induced DNA
damage could restore immune responses to FITC and Can-
dida but not alloantigen (25–27; Kripke, M.L., unpublished
observations). Taken with the recent report that DNA
damage can activate the FasL promoter and upregulate FasL
expression (61), our findings raise the interesting possibility
that UVR-induced DNA damage and FasL are interrelated
in the induction of UVR-induced immune suppression.
The potent induction of FasL mRNA in skin-draining
lymph nodes after UVR lends additional credence to this
premise (Fig. 2).
How might DNA damage, FasL, and immunomodulatory
cytokines interrelate in the induction of UVR-induced im-
mune suppression? First, DNA damage by a variety of
agents, including UV light, has been shown to induce the
expression of both Fas and FasL (3, 36, 61). Our laboratory
has previously demonstrated that cyclobutane pyrimidine
dimer–containing APC are present in the lymph nodes of
UVR-exposed mice (27). Such APC may upregulate FasL
and eliminate responding Fas1 T cells as has been recently
reported for dendritic cells in vitro (42, 54). Second, aber-
rant FasL upregulation coupled with alterations in Fas sen-
sitivity as a result of UVR-induced immunomodulatory
cytokine production may contribute to the termination of
immune responses by inappropriate apoptosis of T cells
and/or APC (38, 40, 41). Third, suppressor T cells re-
sponding to antigen in the context of the UVR cytokine
milieu may differentiate along a novel pathway requiring
FasL as a growth factor (55, 62). Published observations,
along with this report, collectively favor a model in which
UV-induced changes in APC phenotype/function are piv-
otal in the induction of antigen-specific immune suppres-
sion. Our data involving intact and disrupted alloantigen
point toward a requirement for FasL on UVR-exposed
host APC. While such APC are required for the antigen
presentation of FITC, C. albicans, and disrupted alloanti-
gen, intact allogeneic spleen cells may circumvent this re-
quirement by providing a source of FasL while acting as
their own APC. These results suggest that the nature of the
antigen (and thus the APC involved) critically determines
the requirement for host-derived FasL in primary UVR-
induced immune suppression.
What then might be the requirement for FasL in the
generation and activity of transferable suppressor cells?
Considering the low penetrance of UVR in the skin, it ap-
Figure 6. Suppression of DTH responses by adoptively transferred T
suppressor cells does not require host-derived FasL. 108 spleen cells from
indicated donors were injected intravenously into naive C3H or C3H/gld
hosts, sensitized, and challenged with C. albicans as described in Materials
and Methods. Values shown represent mean 6 SE for five mice per
group using measurements from two footpads per mouse. 2, negative
(challenge only); 1, positive (sensitized and challenged); NR, recipient of
spleen cells from NR-sensitized donors, sensitized, and challenged; and
UV, recipient of spleen cells from UV-irradiated sensitized donors, sensi-
tized, and challenged. **P , 0.0001 vs. positive control.
Table I. Immunologic Effects of UV Exposure on
FasL-deficient Mice
Antigen
UV-induced
immunosuppression
UV-induced
suppressor cells
Wild-Type gld/gld Wild-Type gld/gld
FITC 1212
Candida 1212
Alloantigen (whole) 1112
Alloantigen (disrupted) 1212
1 denotes significant suppression (P , 0.05) of antigen responses.
2 denotes an absence of suppression.1291 Hill et al.
pears unlikely that direct UVR exposure and UV-induced
DNA damage occurs on T cells. It is conceivable, how-
ever, that DNA-damaged APC may influence the develop-
ment of such T cells. In this regard, we have previously
shown that DNA-damaged APC cluster with suppressor
T cells in the draining lymph nodes after UVR and antigen
exposure (27, 43, 63). Taken with the observation that Fas
ligation can induce proliferation in some T cells (62), it is
possible that FasL on DNA-damaged APC may act as a
growth factor for UV-induced T suppressor cells in the
context of the UVR-treated animal. Interestingly, Groux
et al. (64) have recently described an IL-10 driven, antigen-
specific CD41 T cell that can potently suppress antigen-
specific immune responses in vivo. Such findings suggest
that UVR-induced immunoregulatory Th2 cytokines such
as IL-10 (18–20) may also participate in the differentiation
and maintenance of the suppressor cell population. On the
other hand, FasL may be required for effector activity of
the UV-induced suppressor cells, perhaps by inducing apop-
tosis in the responding recipient T cell population. Experi-
ments are currently in progress to test these possibilities.
Recent studies highlight the complexity of the immuno-
modulatory effects of UV in vivo. Hart et al. have docu-
mented mast cell–derived histamine as a component of
the UV-induced systemic immunosuppression of DTH re-
sponses to alloantigen (65). In contrast to our studies on
UV-induced systemic immune suppression, Schwartz et al.
have shown a nonessential role for FasL in UV-induced local
immune suppression (66). The local model of UV-induced
immune suppression differs markedly from the systemic
model in both the route of administration (antigen is ad-
ministered through the UV-irradiated site), specific cyto-
kine involvement, and the requirement for FasL. For exam-
ple, UVR-induced suppression of local responses is TNF-a
dependent and IL-10 independent and involves the produc-
tion of cis-urocanic acid (67). In contrast, UVR-induced
systemic immune suppression is independent of both TNF-a
and cis-urocanic acid but dependent upon IL-10 produc-
tion (19, 20; Kripke, M.L., unpublished observations).
Collectively, these findings emphasize mechanistic differ-
ences between UVR-mediated local and systemic suppres-
sion and suggest the existence of at least two nonoverlap-
ping pathways in the generation of systemic UVR-induced
immune suppression. One pathway requires FasL on host-
derived APC and is sensitive to reversal by the repair of
UV-induced DNA damage (25–27; Kripke, M.L., unpub-
lished observations); the other requires histamine (65) and
is independent of host-derived FasL. Interestingly, both
pathways require FasL for the generation of transferable
suppression but may differ in their requirement for FasL in
the host (66).
In summary, our experiments document that Fas/FasL
interactions are essential for UVR-induced systemic sup-
pression of CHS and DTH responses to antigens presented
by host-derived APC (Table I). The requirement for Fas/
FasL in UVR-induced immune suppression can be elimi-
nated if antigen presentation bypasses the requirement for
host-derived APC (intact alloantigen). Moreover, host-
derived, but not recipient-derived, FasL expression is critically
required for the generation and/or function of UVR-induced
suppressor cells. The crucial role of FasL in both systemic
primary and transferable UV-induced immune suppression
suggests that the dysregulation of Fas-mediated apoptosis may
ultimately underlie both processes.
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